ZeroTLR retweeted
#TRILUMINATE #TEER #TriClip RCT @ACCinTouch #ACC2023 late breaker by @psorajja
No diff vs GDMT in ☠️🏩but ⬆️KCCQ ⬇️TR at 1y. Pts DO feel better! Honored to be in this trial and my 1st paper @NEJM! @hahn_rt @caresans26 @SachinGoelMD @mirvatalasnag @KHERA_MD @ParasuramMD
ZeroTLR retweeted
85y♂️ NSTEMI, 5y ago had TAVI in embolized TAVI during same procedure.
Today, PCI to RCA & angiogram to LM done (LAD non-viable). 5Fr RJC advanced over wire between the valves and aortic wall. Spacious STJ was helpful.
ZeroTLR retweeted
#CRT2023 @CathElectroSurg on multivariate prediction model for coronary obstruction in native & ViV #TAVR —
✅ measure cusp ht:coronary ht/sinus ht
✅ measure VTC / VTSTJ (<4mm = ⬆️risk)
✅ measure leaflet calcium volume (>600mm3 = ⬆️risk)
➡️ sig improved sens/spec
@CRT_meeting
ZeroTLR retweeted
#CRT2023
PCI vs CABG for LM dz w & w/out DM
25% DM
DM pts more likely to have higher Syntax & co-morbidities
PEP: all cause ☠️
SEP: CVS & non-CVS ☠️,stroke, peri-procedural & spontaneous MI
No difference in PEP btwn revasc strategy
⬆️ spontaneous MI & repeat revasc w PCI
ZeroTLR retweeted
@JoaoLCavalcante #CRT23
Bicuspid Anatomy for TAVR
The more calcification raphe leaflet LVOT worse mortality
Shorter membranous septal length in BAV
High LV-Ao angle >60 deg
Concomitant coronary anomalies & coronary heights
#Imaging 🔑 to BAV pt selection for TAVR
ZeroTLR retweeted
Current hs-cTn assays are highly valuable for rule-out of AMI. This comes at the price of specificity, unless serial assessments are made. However, serial testing does not differentiate Type 1 from Type 2 AMI and, therefore, robust clinical assessment remains crucial. #CRT2023
ZeroTLR retweeted
First-in-human TELLTALE-BASILICA @StFrancis_LI! TELLTALE is the first and only dedicated system for transcatheter electrosurgical leaflet modification. Life is so much easier with dedicated devices - BASILICA took only a few minutes and the patient did great! Details at #crt2023
ZeroTLR retweeted
✨Glad to share at #CRT2023 our @MonteHeart experience on Prophylactic IABP in TF-TAVI
🌐Out now @EuroInterventio: eurointervention.pcronline.c…
@azeemlatib @jgranadacrf @m_assafin @leoneppmd @MatteoMSturla @CurioJonathan @SebLudwig1 @SpringMD
@MontefioreNYC @EinsteinMed @crfheart – at Washington, DC
ZeroTLR retweeted
Amazing #ValvePPM app by @bapat_savrtavr @hahn_rt @PPibarot on avoiding PPM and check valve function with ref EOA in AVR MVR #TAVR. Must download now to benefit your pts! @JoaoLCavalcante @mirvatalasnag @PCRonline @crfheart @igeorge1975 @AATSHQ @STS_CTsurgery @EACTS @escardio
ZeroTLR retweeted
1/Excited to share our recent @ccijournal publication on the incidence & distribution of missed paravalvular regurgitation (PVR) led by Dr. Syed Zaid @AhmedHaniyehMD & @MalikMD10
& huge thanks to @hasan_ahmadMD @GoldbergJBCTMD @GilbertTangMD
🔗onlinelibrary.wiley.com/doi/…
A 🧵...
ZeroTLR retweeted
Don’t miss @NytvL today #NewYork Transcatheter Valve. World class speakers, 6 live #TAVR #TEER #TMVR cases! @MountSinaiHeart @MountSinaiNYC @IcahnMountSinai @DrSaminSharma @DoctorKini @Drroxmehran @georgedangas @KHERA_MD @ParasuramMD @StamLerakis @DrDavidReich @BethOliverVP
ZeroTLR retweeted
In this multicentre, propensity-matched comparison of the self-expanding ACURATE neo2 and the balloon-expandable SAPIEN 3 Ultra prostheses, the authors found comparably good short-term outcomes but some differences in device success and paravalvular leak. ow.ly/wsyG50LunWt
ZeroTLR retweeted
80y♂️ severe AS heavily ca EF35%,
RBBB, LAD prox-mid 90% calcified lesion. PCI to LAD then #TAVR with #evolute_29. Pre&post🎈. #commisural_alignment #cusp_overlap. shallow implant. No ECG↔️,PG3, NO AI. Easy coronary re-access.
@mirvatalasnag @ZeroTLR @rashaalbawardy @DrAlsaiediAB
ZeroTLR retweeted
Honored to present at #HongKongValves2022 alongside a great lineup of speakers. Hope to go back to my birthplace next year in person! #TAVR #FixTR #TMVR @bapat_savrtavr @TsuyoshiKaneko1 @vonBardelebenRS @CathElectroSurg @m_taramasso @hahn_rt @mirvatalasnag @azeemlatib
ZeroTLR retweeted
NEGATIVE trial. Therefore subgroups are hypothesis generating at best.
Second, no correction made for statistical chance so only point estimates for the many subgroups given in NEJM.
Presentations and ads don’t undergo the same rigour, unfortunately, so a p value has snuck in.
ZeroTLR retweeted
84y♀️ sever AS, perim 62,area 300, SOV 26.6, LM 6.8. #lifetime_management #TAVR @Medtronic #evolute 23mm #cusp_overlap #commisural_alignment
MPG 4, No AI, no ECG change
@DrAlsaiediAB @MogneeA @rashaalbawardy @bogamisa @AlrahimiJ @TAVRBot @mirvatalasnag @GilbertTangMD @colum_owens
ZeroTLR retweeted
⭐️🇮🇹COPS multicenter randomized trial just out as LBCT #TCT2022
Cutting 🔪 vs. non-compliant (NC) 🎈 in Ca++ lesions
At Ca++ site:
🔑 MSA: 8.1 vs. 7.3 mm2 (p =0.035)
🔑 Eccentricity index: 0.84 vs. 0.80 (p =0.013)
@AntonioMangieri @Antocol17 @DamianoRegazzo1 @GLGasparini
